Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
AssigneesUniversite De Bordeaux, Centre Hospitalier Universitaire De Bordeaux
InventorsChristine Leaute-Labreze, Eric Dumas De La Roque, Alain Taieb, Jean-Benoit Thambo
Life of this patent
Estimating the term…
Abstract
The present technology relates the use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas, for example of infantile hemangiomas. The beta blocker may be a non-selective beta-blocker, for example propranolol. The present technology provides an alternative to the known compounds, e.g. corticosteroids, interferon or vincristine, generally used for the treatment of hemangiomas.
Claims16
A method for treating an infant or small child for an infantile hemangioma, the method comprising administering to the infant or small child a medicament comprising a pharmaceutically acceptable and efficient dose of timolol.
A method for treating a hemangioma comprising administering to a patient in need thereof a pharmaceutically acceptable and efficient dose of timolol, wherein the hemangioma is a capillary hemangioma or capillary infantile hemangioma, and the dose administered per day is less than or equal to 5 mg/kg of body weight of the patient.
Dependencies are inferred from the claim text.